Analysis of red blood cell transfusion reactions in China from 2018 to 2023

[Objective] To analyze the demographic characteristics of patients with red blood cell transfusion reactions, the usage of red blood cell preparations, and the differences in the composition ratio of adverse reactions based on multi-center data from the Haemovigilance Network, in order to reveal the...

Full description

Saved in:
Bibliographic Details
Main Authors: PAN Bo, GUAN Xiaoyu, WANG Jue, PAN Yunlong, HE Liu, XU Haixia, JI Xin, TIAN Li, LI Ling, LIU Zhong
Format: Article
Language:zho
Published: Institute of Blood Transfusion of Chinese Academy of Medical Sciences 2025-05-01
Series:Zhongguo shuxue zazhi
Subjects:
Online Access:https://www.cjbt.cn/thesisDetails#10.13303/j.cjbt.issn.1004-549x.2025.05.017&lang=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850253910974922752
author PAN Bo
GUAN Xiaoyu
WANG Jue
PAN Yunlong
HE Liu
XU Haixia
JI Xin
TIAN Li
LI Ling
LIU Zhong
author_facet PAN Bo
GUAN Xiaoyu
WANG Jue
PAN Yunlong
HE Liu
XU Haixia
JI Xin
TIAN Li
LI Ling
LIU Zhong
author_sort PAN Bo
collection DOAJ
description [Objective] To analyze the demographic characteristics of patients with red blood cell transfusion reactions, the usage of red blood cell preparations, and the differences in the composition ratio of adverse reactions based on multi-center data from the Haemovigilance Network, in order to reveal the clinical characteristics of red blood cell transfusion and its underlying issues. [Methods] Clinical data of patients who experienced transfusion reactions after red blood cell transfusion in the Haemovigilance Network from 2018 to 2023 were collected. The demographic characteristics of patients who experienced transfusion reactions with different types of red blood cell preparations, the utilization of these preparations, and the differences of the composition ratios of transfusion reactions were analyzed. Count data were expressed as numbers (n) or percentages (%), and comparisons between groups were performed using the Chi-square test. [Results] Red blood cell transfusion reactions were more common in females (53.56%), with the majority of patients aged 50-69 years (35.54%). The Han polulation accounted for the vast majority of patients (92.77%), and patients in the hematology and obstetrics/gynecology departments had a relatively high proportion of transfusion reactions (13.26% and 14.26%, respectively). Leukocyte-reduced red blood cells and suspended red blood cells were the most common types of transfusion reactions reported among red blood cell preparations. Allergic reactions and non-hemolytic febrile reactions were the most common transfusion reactions, and there were significant differences in the composition ratios of allergic reactions (χ2=869.89, P<0.05) and non-hemolytic febrile reactions (χ2=812.75, P<0.05) across various types of red blood cell preparations. [Conclusion] There are differences in the demographic characteristics and composition ratio of transfusion reactions among different red blood cell preparations. The management of red blood cell transfusion reactions should be tailored to patient characteristics and conditions, and the selection and use of blood products should be optimized to reduce or avoid the occurrence of transfusion reactions, such as considering the use of washed red blood cells for patients with a history of transfusion allergies or those prone to allergies.
format Article
id doaj-art-a26fb2ec106a465883e1921e271cb78f
institution OA Journals
issn 1004-549X
language zho
publishDate 2025-05-01
publisher Institute of Blood Transfusion of Chinese Academy of Medical Sciences
record_format Article
series Zhongguo shuxue zazhi
spelling doaj-art-a26fb2ec106a465883e1921e271cb78f2025-08-20T01:57:15ZzhoInstitute of Blood Transfusion of Chinese Academy of Medical SciencesZhongguo shuxue zazhi1004-549X2025-05-0138570471010.13303/j.cjbt.issn.1004-549x.2025.05.0171004-549X(2025)5-0704-07Analysis of red blood cell transfusion reactions in China from 2018 to 2023PAN Bo0GUAN Xiaoyu1WANG Jue2PAN Yunlong3HE Liu4XU Haixia5JI Xin6TIAN Li7LI Ling8LIU Zhong9Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, ChinaDepartment of Transfusion, The Third People's Hospital of Chengdu (Affiliated Hospital of Southwest Jiaotong University), College of Medicine, Southwest Jiaotong University, Chengdu 610031, ChinaInstitute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, ChinaInstitute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, ChinaInstitute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, ChinaInstitute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, ChinaInstitute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, ChinaInstitute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, ChinaDepartment of Transfusion, The Third People's Hospital of Chengdu (Affiliated Hospital of Southwest Jiaotong University), College of Medicine, Southwest Jiaotong University, Chengdu 610031, ChinaInstitute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, China[Objective] To analyze the demographic characteristics of patients with red blood cell transfusion reactions, the usage of red blood cell preparations, and the differences in the composition ratio of adverse reactions based on multi-center data from the Haemovigilance Network, in order to reveal the clinical characteristics of red blood cell transfusion and its underlying issues. [Methods] Clinical data of patients who experienced transfusion reactions after red blood cell transfusion in the Haemovigilance Network from 2018 to 2023 were collected. The demographic characteristics of patients who experienced transfusion reactions with different types of red blood cell preparations, the utilization of these preparations, and the differences of the composition ratios of transfusion reactions were analyzed. Count data were expressed as numbers (n) or percentages (%), and comparisons between groups were performed using the Chi-square test. [Results] Red blood cell transfusion reactions were more common in females (53.56%), with the majority of patients aged 50-69 years (35.54%). The Han polulation accounted for the vast majority of patients (92.77%), and patients in the hematology and obstetrics/gynecology departments had a relatively high proportion of transfusion reactions (13.26% and 14.26%, respectively). Leukocyte-reduced red blood cells and suspended red blood cells were the most common types of transfusion reactions reported among red blood cell preparations. Allergic reactions and non-hemolytic febrile reactions were the most common transfusion reactions, and there were significant differences in the composition ratios of allergic reactions (χ2=869.89, P<0.05) and non-hemolytic febrile reactions (χ2=812.75, P<0.05) across various types of red blood cell preparations. [Conclusion] There are differences in the demographic characteristics and composition ratio of transfusion reactions among different red blood cell preparations. The management of red blood cell transfusion reactions should be tailored to patient characteristics and conditions, and the selection and use of blood products should be optimized to reduce or avoid the occurrence of transfusion reactions, such as considering the use of washed red blood cells for patients with a history of transfusion allergies or those prone to allergies.https://www.cjbt.cn/thesisDetails#10.13303/j.cjbt.issn.1004-549x.2025.05.017&lang=enred blood cell transfusiontransfusion reactionhaemovigilancepatient characteristics
spellingShingle PAN Bo
GUAN Xiaoyu
WANG Jue
PAN Yunlong
HE Liu
XU Haixia
JI Xin
TIAN Li
LI Ling
LIU Zhong
Analysis of red blood cell transfusion reactions in China from 2018 to 2023
Zhongguo shuxue zazhi
red blood cell transfusion
transfusion reaction
haemovigilance
patient characteristics
title Analysis of red blood cell transfusion reactions in China from 2018 to 2023
title_full Analysis of red blood cell transfusion reactions in China from 2018 to 2023
title_fullStr Analysis of red blood cell transfusion reactions in China from 2018 to 2023
title_full_unstemmed Analysis of red blood cell transfusion reactions in China from 2018 to 2023
title_short Analysis of red blood cell transfusion reactions in China from 2018 to 2023
title_sort analysis of red blood cell transfusion reactions in china from 2018 to 2023
topic red blood cell transfusion
transfusion reaction
haemovigilance
patient characteristics
url https://www.cjbt.cn/thesisDetails#10.13303/j.cjbt.issn.1004-549x.2025.05.017&lang=en
work_keys_str_mv AT panbo analysisofredbloodcelltransfusionreactionsinchinafrom2018to2023
AT guanxiaoyu analysisofredbloodcelltransfusionreactionsinchinafrom2018to2023
AT wangjue analysisofredbloodcelltransfusionreactionsinchinafrom2018to2023
AT panyunlong analysisofredbloodcelltransfusionreactionsinchinafrom2018to2023
AT heliu analysisofredbloodcelltransfusionreactionsinchinafrom2018to2023
AT xuhaixia analysisofredbloodcelltransfusionreactionsinchinafrom2018to2023
AT jixin analysisofredbloodcelltransfusionreactionsinchinafrom2018to2023
AT tianli analysisofredbloodcelltransfusionreactionsinchinafrom2018to2023
AT liling analysisofredbloodcelltransfusionreactionsinchinafrom2018to2023
AT liuzhong analysisofredbloodcelltransfusionreactionsinchinafrom2018to2023